Skip to main content
Figure 5 | BMC Cancer

Figure 5

From: Direct confirmation of quiescence of CD34+CD38- leukemia stem cell populations using single cell culture, their molecular signature and clinicopathological implications

Figure 5

Clinical implication of the proportion of ASCs. (A, C) Compared to an ASC ratio of <0.1, an ASC ratio of >0.1 in the AML patients group resulted in a shorter overall survival, similar to that observed in cytogenetic risk groups, albeit without statistical significance (p = 0.211). (B, D) There was no statistically significant difference in relapse-free survival with respect to ASC ratio.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us